跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 239 条关于
“NN-Dimethyltryptamine”
全部
239
临床试验
59
药物
156
机构
1
资讯
23
上个月
Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion in Landmark Psychedelic Medicine Deal
去年
NanoNewron Secures $2.5M NIH Grant to Advance Blood-Brain Barrier Crossing TNF-Alpha Inhibitor for Alzheimer's Disease
2年前
Psychedelics Show Promise in Clinical Settings but Require Enhanced Safety Monitoring
去年
Cybin Advances Psychedelic Therapeutics for Mental Health Disorders, Eyes 2025 Milestones
5年前
Psilera Partners with Worldwide for Accelerated Clinical Development of DMT Patch
去年
atai Life Sciences Advances Psychedelic Therapy Pipeline with Key Clinical Milestones and Extended Financial Runway
去年
Cybin's CYB003 Shows Sustained Efficacy in Phase 2 Major Depressive Disorder Trial
去年
Oral GLP-1R Obesity Drugs Race to Market as Novo Nordisk and Eli Lilly Lead Phase III Trials
去年
Norovirus Vaccine Development Advances with mRNA and Oral Tablet Candidates
去年
Cybin's CYB003 Demonstrates Sustained Efficacy in Phase 2 Trial for Major Depressive Disorder
第 1 页,共 3 页
上一页
下一页